IRIS
QUERCIOLI, ALESSANDRA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.991
Totale 5.991
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.991
Totale 5.991
Salva come PNG Salva come JPEG
Città #
Genova 4.688
Genoa 448
Vado Ligure 445
Rapallo 396
Bordighera 14
Totale 5.991
Salva come PNG Salva come JPEG
Nome #
The vulnerable coronary plaque: update on imaging technologies. 174
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. 174
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 161
Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity. 152
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. 151
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 143
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 141
Statins in the treatment of acute ischemic stroke. 139
Anti-apolipoprotein a-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals. 138
Update on the treatments of non-alcoholic fatty liver disease (NAFLD). 138
Inflammation in the pathophysiology of essential hypertension. 136
New evidence for nicotinic acid treatment to reduce atherosclerosis. 135
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury 133
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). 132
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function 128
Clorhexidine prevents hypoclorous acid-induced inactivation of alpha1-antitrypsin. 127
Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. 123
Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways. 123
Intestinal radiation-induced stricture favours small bowel obstruction by phytobezoar: report of a case 120
The need of identifying circulating biomarkers of coronary dysfunction 117
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. 115
Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. 113
Impact of obesity and bariatric surgery on metabolism and coronary circulatory function. 113
Quantitative PET/CT measures of myocardial flow reserve and atherosclerosis for cardiac risk assessment and predicting adverse patient outcomes. 113
Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT. 113
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. 110
Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease. 110
Quantitative assessment of myocardial blood flow--clinical and research applications. 107
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 107
Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight. 106
RANKL/OPG pathway is a promising target to reduce atherosclerosis plaque calcification. 104
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 102
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. 98
Ezetimibe/simvastatin. 94
Role of neutrophils in acute myocardial infarction. 93
Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. 93
Heart failure and chronic kidney disease in a registry of internal medicine wards 92
Plasma concentrations of edocannabinoid are associated with dysfunction of the coronary microcirculation in obese subjects. 89
Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CT. 89
Improvement in Coronary Endothelial Function is Independently Associated with a Slowed Progression of Coronary Artery Calcification in Type 2 Diabetes Mellitus. 87
The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow. 86
Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects 84
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 81
Receptor activator of NF-kappa B ligand (RANKL) increases neutrophilic degranulation and potentially associated cardiovascular risk. 79
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 76
A Genetic Polymorphism in the Pannexin1 Gene Predisposes for The Development of Endothelial Dysfunction with Increasing BMI 75
Left ventricular dyssynchrony assessment by phase analysis from gated myocardial perfusion SPECT: moving beyond conventional criteria. 74
Inferior vena cava parameters predict readmission in ischemic heart failure. 74
Statin Treatment Is Associated with Reduction in Serum Levels of Receptor Activator of NF-kappaB Ligand and Neutrophil Activation in Patients with Severe Carotid Stenosis. 74
New evidences for a direct involvement of neutrophils in atherosclerosis. 72
Sulphasalazin accelerates apoptosis in neutrophils exposed to immune complex: role of caspase pathway. 70
Novel treatment strategy with direct renin inhibition against heart failure. 68
Effect of NH3 metabolite correction on the myocardial blood flow measurement. 68
Inter and intra operator variability of myocardial blood flow quantification using dynamic NH3 and Rb PET. 64
Effect of gastric bypass on vasomotor function of the coronary circulation in morbid obese individuals without cardiovascular diseases. 63
PET-Determined Hyperemic Longitudinal, Myocardial Flow Gradient as Noninvasive Probe of Epicardial Vasomotion in Cardiovascular Risk Individuals with or Without Coronary Artery Calcifications. 56
Mechanisms underlying endothelial dysfunction in obstructive sleep apnea syndrome (OSAS) patients. 49
Plasma palmitoylethanolamide as potential predictor of coronary dysfunction. 45
Totale 6.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.649
article - articoli 17.017
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 632
Totale 35.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.196 0 0 0 0 0 0 349 160 176 285 162 64
2020/2021446 34 43 20 57 18 45 5 62 33 55 26 48
2021/2022736 37 74 26 89 54 50 61 160 20 58 29 78
2022/2023518 77 42 8 30 61 93 1 34 79 2 80 11
2023/2024293 10 46 8 41 21 75 16 18 15 5 7 31
2024/2025492 19 70 24 51 196 128 4 0 0 0 0 0
Totale 6.091